Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Chronic lymphocytic leukaemia: current management].
Aurran-Schleinitz T, Arnoulet C, Ivanov V, Coso D, Rey J, Schiano JM, Stoppa AM, Bouabdallah R, Gastaut JA. Aurran-Schleinitz T, et al. Among authors: bouabdallah r. Rev Med Interne. 2008 May;29(5):424-35. doi: 10.1016/j.revmed.2007.10.414. Epub 2007 Nov 20. Rev Med Interne. 2008. PMID: 18359538 Review. French.
[Chronic myeloid leukemia, biological aspects].
Costello R, Bouabdallah R, Sainty D, Gastaut JA, Gabert J. Costello R, et al. Among authors: bouabdallah r. Rev Med Interne. 1996;17(3):213-23. doi: 10.1016/0248-8663(96)81248-3. Rev Med Interne. 1996. PMID: 8734143 Review. French.
Primary plasma cell leukaemia: a report of 18 cases.
Costello R, Sainty D, Bouabdallah R, Fermand JP, Delmer A, Diviné M, Marolleau JP, Gastaut JA, Olive D, Rousselot P, Chaïbi P. Costello R, et al. Among authors: bouabdallah r. Leuk Res. 2001 Feb;25(2):103-7. doi: 10.1016/s0145-2126(00)00102-8. Leuk Res. 2001. PMID: 11166824 Review.
Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): final analysis of survival in two consecutive ISC trials.
Bouabdallah R, Stoppa AM, Coso D, Bardou VJ, Blaise D, Chabannon C, Gastaut JA, Maraninchi D. Bouabdallah R, et al. Ann Oncol. 2001 Apr;12(4):513-7. doi: 10.1023/a:1011160207382. Ann Oncol. 2001. PMID: 11398886 Free article.
[Primary mediastinal B-cell lymphoma].
Coso D, Rey J, Bouabdallah R. Coso D, et al. Among authors: bouabdallah r. Rev Pneumol Clin. 2010 Feb;66(1):32-5. doi: 10.1016/j.pneumo.2009.12.007. Epub 2010 Feb 11. Rev Pneumol Clin. 2010. PMID: 20207294 Review. French.
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
Coso D, Sebban C, Boulat O, Biron P, Rey J, Aurran T, Chabannon C, Xerri L, Chetaille B, Esterni B, Ivanov V, Stoppa AM, Schiano de Collela JM, Gastaut JA, Maraninchi D, Bouabdallah R. Coso D, et al. Among authors: bouabdallah r. Bone Marrow Transplant. 2006 Aug;38(3):217-22. doi: 10.1038/sj.bmt.1705414. Epub 2006 Jun 12. Bone Marrow Transplant. 2006. PMID: 16770316 Clinical Trial.
271 results